Multimodal imaging with 18F-FDG-PET/CT and 111In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma

被引:0
|
作者
Serena De Luca
Rosa Fonti
Luigi Camera
Barbara Salvatore
Antongiulio Faggiano
Andrea Ciarmiello
Sabrina Segreto
Annamaria Colao
Marco Salvatore
Silvana Del Vecchio
机构
[1] University of Naples Federico II,Department of Advanced Biomedical Sciences
[2] National Research Council,Institute of Biostructures and Bioimages
[3] University of Naples Federico II,Department of Clinical Medicine and Surgery
[4] Hospital S. Andrea,Nuclear Medicine Department
[5] IRCCS-SDN,undefined
来源
关键词
Medullary thyroid carcinoma; F-FDG-PET/CT; In-Octreotide SPECT; Contrast-enhanced CT; Multimodal imaging;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:234 / 241
页数:7
相关论文
共 50 条
  • [31] The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT
    Beheshti, Mohsen
    Poecher, Sigrid
    Vali, Reza
    Waldenberger, Peter
    Broinger, Gabriele
    Nader, Michael
    Kohlfuerst, Susanne
    Pirich, Christian
    Dralle, Henning
    Langsteger, Werner
    EUROPEAN RADIOLOGY, 2009, 19 (06) : 1425 - 1434
  • [32] Neuroendocrine tumors (NET) imaging: A comparative analysis of 18F-FDG pet, 111In-octreotide scan and conventional radiology
    Pasquali, C
    Rubello, D
    Gasparoni, P
    Sperti, C
    Chierichetti, F
    Liessi, G
    Ferlin, G
    Pedrazzoli, S
    GASTROENTEROLOGY, 1997, 112 (04) : A471 - A471
  • [33] The value of 18F-FDG PET/CT and 18F-DOPA PET/CT in determining the initial surgical strategy of patients with medullary thyroid cancer: Preoperative PET/CT imaging for medullary thyroid cancer
    Jager, Eline C.
    Brouwers, Adrienne H.
    Metman, Madelon J. H.
    Aykan, Dilay
    de Vries, Lisa H.
    Lodewijk, Lutske
    Vriens, Menno R.
    Kruijff, Schelto
    Links, Thera P.
    CANCER IMAGING, 2025, 25 (01)
  • [34] 18F-FDG-PET predicts clinical outcome in patients with differentiated thyroid carcinoma
    Rahbar, K.
    Weckesser, M.
    Zoubi, T.
    Schober, O.
    Riemann, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S129 - S129
  • [35] Impact of 18F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma
    Ozkan, Elgin
    Soydal, Cigdem
    Kucuk, Ozlem N.
    Ibis, Erkan
    Erbay, Guner
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [36] Impact of 18F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma
    Ozkan, Elgin
    Soydal, Cigdem
    Kucuk, Ozlem N.
    Ibis, Erkan
    Erbay, Guner
    NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (12) : 1162 - 1168
  • [37] Impact of 18F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma
    Ozkan, E.
    Soydal, C.
    Kucuk, O. N.
    Ibis, E.
    Erbay, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S347 - S347
  • [38] F-18-DOPA PET/CT in medullary thyroid carcinoma patients
    Golubic, A. T.
    Pasini, E.
    Zuvic, M.
    Kuna, S. Kusacic
    Samardzic, T.
    Despot, M.
    Huic, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S692 - S692
  • [39] 18F-FDG-PET/CT in myelofibrosis
    Behrendt, F. F.
    Krohn, T.
    Palmowski, M.
    Mottaghy, F. M.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2011, 50 (06): : N66 - N67
  • [40] Role of 18F-FDG PET/CT fusion imaging in detecting recurrent medullary thyroid carcinoma (MTC)
    Banti, E.
    Rampin, L.
    Nanni, C.
    Ferdeghini, M.
    Fanti, S.
    Rubello, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S198 - S198